The average drug takes 10+ years and $2.3B to bring to market—with a 90% failure rate in clinical trials. AI is rewriting this equation. By 2025, AI-driven drug discovery is projected to slash ...
SELARSDI is approved for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis in adults and pediatric patients 6 years and older, and the treatment of adult patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback